Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
Supportive Care in Cancer, 06/20/2012
Garcia JM et al. – The findings suggest that anamorelin showed significant metabolic, clinical, and patient–rated effects in cancer cachexia.



